BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35973872)

  • 1. Infection status and survival impact of high-risk human papillomavirus in cervical adenocarcinomas: A systematic review and meta-analysis.
    Chen H; Xiong W; Dong X; Liu Y; Tan X
    Gynecol Oncol; 2022 Oct; 167(1):129-136. PubMed ID: 35973872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis.
    Volesky-Avellaneda KD; Laurie C; Tsyruk-Romano O; El-Zein M; Franco EL
    Obstet Gynecol; 2023 Nov; 142(5):1055-1067. PubMed ID: 37856917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
    Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
    PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
    Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
    Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women.
    Zhong F; Yu T; Ma X; Wang S; Cong Q; Tao X
    Dis Markers; 2022; 2022():8130373. PubMed ID: 35722626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and genotype distribution of human papillomavirus in cervical adenocarcinoma (usual type and variants): A systematic review and meta-analysis.
    Reynders C; Lerho T; Goebel EA; Crum CP; Vandenput S; Beaudart C; Herfs M
    J Med Virol; 2023 Oct; 95(10):e29190. PubMed ID: 37861377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.
    Adebamowo SN; Adeyemo AA;
    Hum Immunol; 2019 Sep; 80(9):723-730. PubMed ID: 31072753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: a meta analysis].
    Yuanyuan X; Suling H; Quan Z; Shixun Z; Yucheng Y; Houyong K; Guohua H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 50(3):236-43. PubMed ID: 26268498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with meta-analysis: the association between human papillomavirus infection and oesophageal cancer.
    Li X; Gao C; Yang Y; Zhou F; Li M; Jin Q; Gao L
    Aliment Pharmacol Ther; 2014 Feb; 39(3):270-81. PubMed ID: 24308856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.
    Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Sun X
    Oncotarget; 2017 May; 8(21):34507-34515. PubMed ID: 28427144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis.
    Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW
    Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix.
    Stuebs FA; Gass P; Dietl AK; Schulmeyer CE; Adler W; Geppert C; Hartmann A; Knöll A; Beckmann MW; Koch MC
    Arch Gynecol Obstet; 2021 Sep; 304(3):751-758. PubMed ID: 33538863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
    JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of high-risk human papillomavirus DNA and p16
    Obermueller T; Hautekiet J; Busto MP; Reynders D; Belgioia L; Cats A; Gilbert DC; Koerber SA; Mai S; Meulendijks D; Rödel F; Yhim HY; Hetjens S; Weiß C; Rasmussen CL; Urbute A; Verdoodt F; Kjaer SK; Reuschenbach M; Goetghebeur E; von Knebel Doeberitz M; Arbyn M; Prigge ES
    Eur J Cancer; 2021 Nov; 157():165-178. PubMed ID: 34517306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection in China.
    Zeng Z; Austin RM; Wang L; Guo X; Zeng Q; Zheng B; Zhao C
    Am J Clin Pathol; 2022 May; 157(5):718-723. PubMed ID: 34724029
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.